Department of Animal Science, Penn State University, University Park 16802.
Department of Animal Science, Université Laval, Québec, QC, Canada G1V 0A6.
J Dairy Sci. 2018 May;101(5):4259-4267. doi: 10.3168/jds.2017-13452. Epub 2018 Feb 15.
Rumen microbial biohydrogenation (BH) of unsaturated fatty acids (UFA) has been extensively studied in vitro; however, in vitro BH pathways, rates, and extents may not parallel those in vivo. The objective was to develop an assay to assess in vivo rates, pathways, and extent of BH of oleic (OA), linoleic (LA), and α-linolenic (ALA) acids. Each UFA was characterized in a separate experiment, each using 4 ruminally cannulated lactating Holstein cows. A single bolus consisting of 200 g of a UFA-oil [experiment 1 (EXP1): 87% OA sunflower, experiment 2 (EXP2): 70% LA safflower, and experiment 3 (EXP3): 54% ALA flaxseed] and 12 g of heptadecanoic acid (C17:0) was mixed into the rumen through the fistula. Rumen digesta was collected at -1, -0.25, 0.1, 0.25, 0.5, 0.75, 1, 1.5, 2, 3, 4, and 6 h relative to the bolus. Overall, the triglyceride boluses increased total fatty acids (FA) in the rumen from 3.9 (standard deviation = ±1.4) to 7.3% (±1.4) of rumen dry matter and enriched C17:0 from 0.4 (±0.1) to 2.5% (±0.5) of FA. The bolus enriched OA from 8.9 (±1.0) to 30.1% (±4.6) of FA in EXP1, LA from 11.1 (±1.8) to 35.9% (±5.0) of FA in EXP2, and ALA from 2.1 (±0.1) to 19.8% (±4.3) of FA in EXP3. The disappearances of C17:0, OA, LA, and ALA were fit to a single exponential decay model. The first-order rate of C17:0 rumen disappearance (turnover) was 9.1, 6.9, and 5.2%/h in EXP1, EXP2, and EXP3, respectively, and was used as a marker of FA passage. The rate of total rumen turnover of OA was 54.1%/h, LA was 60.5%/h, and ALA was 93.0%/h in EXP1, EXP2, and EXP3, respectively. Rumen concentration of all 3 UFA reached prebolus concentrations within 4 h. The calculated extent of lipolysis and initial isomerization was 85.6% for OA, 89.8% for LA, and 94.7% for ALA in EXP1, EXP2, and EXP3, respectively. Assuming that BH equals total disappearance minus passage, the rates of lipolysis and initial isomerization were 45.0, 53.6, and 87.8%/h for OA, LA, and ALA in EXP1, EXP2, and EXP3, respectively. Analysis of the data using compartmental modeling showed that the normal BH pathways proposed in the literature explained 46.0, 37.3, and 49.8% of the BH of OA, LA, and ALA in EXP1, EXP2, and EXP3, respectively. Based on the model, BH of trans C18:1 FA was the rate-limiting step to complete BH. Importantly, oils were provided as triglycerides and the reported rates represent the rate of lipolysis and BH. In conclusion, the rate of ruminal BH of OA, LA, and ALA was higher than that commonly observed in vitro, but the extent of BH was near expected values. The method developed provides a potential in vivo assay of ruminal BH for use in future experiments and modeling efforts.
反刍动物瘤胃微生物生物氢化(BH)不饱和脂肪酸(UFA)在体外已经得到了广泛的研究;然而,体外 BH 途径、速率和程度可能与体内的情况不一致。本研究旨在建立一种评估油酸(OA)、亚油酸(LA)和α-亚麻酸(ALA)体内 BH 速率、途径和程度的方法。每个 UFA 都在单独的实验中进行了特征描述,每个实验都使用 4 头瘤胃瘘管泌乳荷斯坦奶牛。含有 200 g UFA-油[实验 1(EXP1):87%OA 葵花籽油,实验 2(EXP2):70%LA 红花籽油,实验 3(EXP3):54%ALA 亚麻籽油]和 12 g 十七烷酸(C17:0)的单一弹丸通过瘘管注入瘤胃。相对于弹丸,在-1、-0.25、0.1、0.25、0.5、0.75、1、1.5、2、3、4 和 6 h 收集瘤胃液。总的来说,甘油三酯弹丸使瘤胃总脂肪酸(FA)从瘤胃干物质的 3.9%(标准偏差=±1.4)增加到 7.3%(±1.4),并使 C17:0 从 0.4%(±0.1)增加到 2.5%(±0.5)的 FA。弹丸使 EXP1 中 OA 从 8.9%(±1.0)增加到 30.1%(±4.6),LA 从 11.1%(±1.8)增加到 35.9%(±5.0),ALA 从 2.1%(±0.1)增加到 19.8%(±4.3)的 FA。C17:0、OA、LA 和 ALA 的消失符合单指数衰减模型。EXP1、EXP2 和 EXP3 中 C17:0 瘤胃消失(周转率)的一级速率分别为 9.1%、6.9%和 5.2%/h,可用作 FA 传递的标记物。OA 总瘤胃周转率为 54.1%/h,LA 为 60.5%/h,ALA 为 93.0%/h,EXP1、EXP2 和 EXP3 分别为 93.0%/h。在 4 h 内,所有 3 种 UFA 的瘤胃浓度均恢复到弹丸前的浓度。计算得出的脂解和初始异构化程度分别为 EXP1、EXP2 和 EXP3 中 OA 的 85.6%、LA 的 89.8%和 ALA 的 94.7%。假设 BH 等于总消失减去传递,则 EXP1、EXP2 和 EXP3 中 OA、LA 和 ALA 的脂解和初始异构化速率分别为 45.0%、53.6%和 87.8%/h。使用房室模型对数据进行分析表明,文献中提出的正常 BH 途径分别解释了 EXP1、EXP2 和 EXP3 中 OA、LA 和 ALA 的 BH 的 46.0%、37.3%和 49.8%。基于该模型,反式 C18:1 FA 的 BH 是完全 BH 的限速步骤。重要的是,油是以甘油三酯的形式提供的,报告的速率代表脂解和 BH 的速率。总之,OA、LA 和 ALA 的瘤胃 BH 速率高于体外通常观察到的速率,但 BH 的程度接近预期值。所开发的方法为未来的实验和建模工作提供了一种瘤胃 BH 的体内测定方法。